Edoxaban Onset and Plasma Level Measurement
Edoxaban reaches peak plasma concentration at 1.3 hours after oral administration, and steady-state anticoagulant effects are achieved within 3 days. 1
Time to Anticoagulant Effect
- Peak effect: 1-2 hours after a single dose 2
- Peak plasma concentration: 1.3 hours after oral administration 1
- Steady-state: 3 days of regular dosing 1
The anticoagulant effect begins rapidly after the first dose, with measurable changes in coagulation markers occurring within 1-2 hours. However, the full therapeutic effect stabilizes after approximately 3 days of continuous therapy, which corresponds to approximately 3-4 half-lives (elimination half-life is 9-11 hours) 1.
Plasma Level Measurement
Yes, edoxaban plasma levels can be measured using chromogenic anti-factor Xa assays with drug-specific calibration. 2
When to Measure
Blood sampling should be done at peak (1-2 hours post-dose) or trough (just before next dose) for accurate interpretation. 2
- Peak levels: 1-2 hours after dose administration
- Trough levels: Just before the next scheduled dose (approximately 24 hours after the previous dose for once-daily dosing)
Expected Therapeutic Ranges
For standard-dose edoxaban 2:
- Peak plasma levels: 91-321 ng/mL
- Trough plasma levels: 31-230 ng/mL
Measurement Methods
The chromogenic anti-factor Xa assay with edoxaban-specific calibration is the preferred method for quantifying plasma levels. 2
- Chromogenic anti-Xa assay: Most accurate, linear relationship across therapeutic range, results available within 30 minutes 2
- Prothrombin time (PT): May provide some quantitative information for edoxaban (unlike apixaban), but sensitivity varies significantly between reagents and is generally insufficient 2
- aPTT: Insufficient sensitivity; not recommended for edoxaban measurement 2
Important Caveats
Routine monitoring is NOT required for edoxaban therapy 2
Plasma level measurement should be reserved for specific situations:
- Emergency bleeding situations
- Urgent surgery with high bleeding risk
- Suspected overdose or intoxication
- Uncertain timing of last dose
- Concerns about drug clearance (renal impairment, drug interactions) 2
Point-of-care INR devices do NOT accurately reflect edoxaban anticoagulant status 2
When measuring levels, timing relative to the last dose is critical for proper interpretation—peak vs. trough levels differ substantially 2
Most routine coagulometers can measure edoxaban plasma levels within 30 minutes using appropriate assays, and institutions should consider 24/7 availability for emergency situations 2